Histogen (HSTO) Competitors $0.03 0.00 (0.00%) As of 05/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock HSTO vs. MYMD, KRBP, CAPS, TFFP, TCBP, VRPX, PTPI, NCNA, UPC, and BONShould you be buying Histogen stock or one of its competitors? The main competitors of Histogen include MyMD Pharmaceuticals (MYMD), Kiromic BioPharma (KRBP), Capstone (CAPS), TFF Pharmaceuticals (TFFP), TC Biopharm (TCBP), Virpax Pharmaceuticals (VRPX), Petros Pharmaceuticals (PTPI), NuCana (NCNA), Universe Pharmaceuticals (UPC), and Bon Natural Life (BON). These companies are all part of the "pharmaceutical products" industry. Histogen vs. MyMD Pharmaceuticals Kiromic BioPharma Capstone TFF Pharmaceuticals TC Biopharm Virpax Pharmaceuticals Petros Pharmaceuticals NuCana Universe Pharmaceuticals Bon Natural Life Histogen (NASDAQ:HSTO) and MyMD Pharmaceuticals (NASDAQ:MYMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, community ranking, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation. Do institutionals and insiders have more ownership in HSTO or MYMD? 9.6% of MyMD Pharmaceuticals shares are owned by institutional investors. 3.3% of Histogen shares are owned by company insiders. Comparatively, 2.1% of MyMD Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, HSTO or MYMD? Histogen has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, MyMD Pharmaceuticals has a beta of 2.15, suggesting that its share price is 115% more volatile than the S&P 500. Does the media favor HSTO or MYMD? In the previous week, Histogen's average media sentiment score of 0.00 equaled MyMD Pharmaceuticals'average media sentiment score. Company Overall Sentiment Histogen Neutral MyMD Pharmaceuticals Neutral Is HSTO or MYMD more profitable? Histogen's return on equity of 0.00% beat MyMD Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets HistogenN/A N/A N/A MyMD Pharmaceuticals N/A -179.05%-108.14% Which has higher valuation and earnings, HSTO or MYMD? MyMD Pharmaceuticals has lower revenue, but higher earnings than Histogen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHistogen$19K6.98-$10.62M-$2.81-0.01MyMD PharmaceuticalsN/AN/A-$4MN/AN/A Does the MarketBeat Community favor HSTO or MYMD? Histogen received 7 more outperform votes than MyMD Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformHistogenOutperform Votes758.33% Underperform Votes541.67% MyMD PharmaceuticalsN/AN/A SummaryHistogen beats MyMD Pharmaceuticals on 5 of the 8 factors compared between the two stocks. Get Histogen News Delivered to You Automatically Sign up to receive the latest news and ratings for HSTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSTO vs. The Competition Export to ExcelMetricHistogenPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$133,000.00$6.50B$5.34B$8.42BDividend YieldN/A2.64%5.21%4.11%P/E Ratio-0.019.1526.8519.72Price / Sales6.98252.36387.23121.26Price / CashN/A65.8538.2534.62Price / Book0.016.456.774.51Net Income-$10.62M$144.21M$3.23B$248.32M7 Day PerformanceN/A2.38%1.81%0.60%1 Month PerformanceN/A4.50%10.93%13.18%1 Year PerformanceN/A-2.75%17.15%7.39% Histogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSTOHistogenN/A$0.03flatN/A-81.7%$133,000.00$19,000.00-0.0120MYMDMyMD PharmaceuticalsN/A$0.19-4.3%N/A-91.4%$448,000.00N/A0.006High Trading VolumeKRBPKiromic BioPharmaN/AN/AN/AN/A$330,000.00N/A-0.0660News CoverageGap DownHigh Trading VolumeCAPSCapstoneN/A$1.97-5.7%N/AN/A$311,000.00$44.88M0.0038News CoveragePositive NewsGap DownTFFPTFF PharmaceuticalsN/A$0.07flatN/AN/A$289,000.00$-70,983.00-0.0119TCBPTC Biopharm1.2322 of 5 stars$0.68-55.8%$48.00+6,948.5%-99.6%$279,000.00$4.76M0.0080High Trading VolumeVRPXVirpax Pharmaceuticals0.8936 of 5 stars$0.22-5.2%$75.00+33,990.9%-98.8%$273,000.00N/A0.007Gap UpPTPIPetros Pharmaceuticals0.7741 of 5 stars$0.12-6.1%N/A-99.6%$265,000.00$5.11M-0.0320News CoverageEarnings ReportGap UpHigh Trading VolumeNCNANuCana2.2147 of 5 stars$0.05-3.7%$25.00+53,779.3%-98.9%$264,000.00N/A0.0030High Trading VolumeUPCUniverse PharmaceuticalsN/A$6.03-4.1%N/A-99.6%$259,000.00$23.02M0.00220Gap UpBONBon Natural LifeN/A$1.52+16.9%N/A-98.0%$254,000.00$23.84M0.00100Gap UpHigh Trading Volume Related Companies and Tools Related Companies MyMD Pharmaceuticals Competitors Kiromic BioPharma Competitors Capstone Competitors TFF Pharmaceuticals Competitors TC Biopharm Competitors Virpax Pharmaceuticals Competitors Petros Pharmaceuticals Competitors NuCana Competitors Universe Pharmaceuticals Competitors Bon Natural Life Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSTO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSTO Stock Free HSTO Stock Alerts